Yeast expression system produces recombinant pharmaceuticals employing Saccharomyces cerevisiae or Pichia pastoris. Plasmid vectors carry target genes into yeast cells. Protein secretion into culture media simplifies purification. Scalable fermentation produces commercial quantities. Post-translational modifications enhance biological activity.
Regulatory submissions include expression system characterisation. Quality control monitors product consistency. Manufacturing scale-up validates process. Post-approval surveillance confirms product stability. Emerging yeast strains enhance production.
General Biopharmaceutical Concepts
Yeast Expression System
A yeast expression system uses genetically engineered yeast cells to produce recombinant proteins, vaccines and other biopharmaceutical products.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →